UCSD

Moores UCSD Cancer Center Luau & Longboard Invitational Celebrates 16 Years of 'Surfing for a Cure' to Raise Funds for Cancer Research

LA JOLLA, Calif., July 27 /PRNewswire/ -- For the past 16 years, beachgoers have been invited to watch respected surfers, business leaders, community members and cancer survivors "surfing for a cure" at the annual Moores UCSD Cancer Center Luau & Longboard Invitational held at U...

Moores UCSD Cancer Center Luau and Longboard Invitational Hosts Survivor Beach Aug. 9

LA JOLLA, Calif., July 10 /PRNewswire/ -- Surfers, cancer survivors and supporters will gather on Sunday, August 9 on the shore of the Pacific Ocean with a special purpose: to show their support for the fight against cancer. As participants in the third annual Survivor Beach, they will place ...

Moores UCSD Cancer Center Luau and Longboard Invitational Announce Dr. David Easter to Receive the 2009 Rell Sunn 'Queen of Makaha' Award

Brilliant Doctor Brings the 'Aloha Spirit' into a Patient-Centered Approach to Surgical Medicine and Training SAN DIEGO, June 19 /PRNewswire/ -- The Moores UCSD Cancer Center Luau & Longboard Invitational announced today that David Easter, M.D., director of the General Surgery Residency...

HBO, UCSD Shiley-Marcos Alzheimer's Disease Research Center, The Alzheimer's Association San Diego/Imperial Chapter and The Neurosciences Institute Present an Advance Screening of THE ALZHEIMER'S PROJECT: 'MOMENTUM IN SCIENCE'

FREE TO THE PUBLIC Panel Discussion To Follow With Local Leading Alzheimer's Experts Featured In Film SAN FRANCISCO, April 9 /PRNewswire/ -- A free screening of HBO Documentary Films' THE ALZHEIMER'S PROJECT: MOMENTUM IN SCIENCE will be held at The Neurosciences Institute (10640 John J...

Moores UCSD Cancer Center studying novel leukemia vaccine for high-risk patients

Researchers at the Moores Cancer Center at the University of California, San Diego (UCSD) are conducting clinical trials of a novel therapy aimed at revving up the immune system to combat a particularly difficult-to-treat form of leukemia. The experimental therapy is being offered to patients ...

Novel Lung Cancer Vaccine Trial Launched at Moores UCSD Cancer Center

Oncologists at the Moores Cancer Center at the University of California, San Diego (UCSD) in La Jolla are hoping to stave off the relentless march of advanced lung cancer by treating patients with a novel kind of cancer vaccine. While many vaccines attempt to pump up the immune system to fight off...

Surgical Care Affiliates and UCSD Medical Center to Partner in Surgical Center

BIRMINGHAM, Ala., Dec. 26 /PRNewswire/ -- Surgical Care Affiliates (SCA), one of the country's largest providers of specialty surgical services, announced today that it has entered into a joint venture relationship with University of California San Diego (UCSD) Medical Center to partner in the...

ISCAR, world-wide conference on role of culture in human development, convenes at UCSD

The Second Congress of the International Society for Cultural and Activity Research (ISCAR) will take place at the University of California, San Diego, Sept. 8-13, 2008. Nearly 1,000 researchers from 40 countries will attend the conference with others participating from around the globe via state-...

New UCSD Program to Fight Drug-Resistant Bacteria

In response to the major public health threat posed by antibiotic-resistant bacteria, researchers at the University of California, San Diego (UCSD) are launching a new program to develop novel// antibiotics – from initial discovery, through development and testing, to clinical trials. "UCSD i...

11th Annual Light the Night Date Announced

...his night of fun and fundraising." Past participating companies include Kohl's, Burlington Coat Factory, Cricket Communications, Biogen Idec, ucsd Moore's Cancer Center, Ruby's Diner, GEICO and many more. Tina Fey is the National Spokesperson for the 2009 Light the Night Walk. The Leukem...

UCSD in Medical Technology

The Leukemia & Lymphoma Society and Memgen Announce New Chronic Lymphocytic Leukemia Clinical Trial

...c lymphocytic leukemia (CLL). Doctors at ucsd have already begun treating the first patient with... Castro, M.D., assistant clinical professor at the ucsd School of Medicine and the Moores Cancer Center, w...inical trial, contact Denise Darrah, at the Moores ucsd Cancer Center, 858-822-5375, or ddarrah@ucsd.edu ...

Raptor Pharmaceuticals to Collaborate with Centre Hospitalier Universitaire d'Angers for Phase II Clinical Trial in Huntington's Disease

...tial indications including Huntington's, cystinosis, non-alcoholic steatohepatitis ("NASH") and Batten Disease. Raptor is currently collaborating with ucsd in an ongoing phase IIa clinical study of cysteamine in NASH patients. Raptor plans to initiate a pivotal study of DR Cysteamine in cystinosis patient...

Raptor Pharmaceuticals Announces Phase 2a Clinical Trial Initiation in Non-Alcoholic Steatohepatitis (NASH)

...potential efficacy of cysteamine in NASH patients, ucsd is performing the Phase 2a open-label clinical stu...vine, M.D., Ph.D., pediatric gastroenterologist at ucsd and principal investigator for the NASH study, com...ve worldwide license to intellectual property from ucsd for the use of cysteamine and DR Cysteamine for th...

Raptor Pharmaceuticals Enters Collaboration Agreement with UC San Diego in Liver Disease

...r in the U.S. Under the terms of the Agreement, clinical researchers from ucsd will perform the Phase 2a study at the University's General Clinical Resear...ldwide license to certain intellectual property and development rights from ucsd surrounding the use of Cysteamine as a potential treatment for NASH. A ra...

Jennerex Publishes Promising Results from Cancer Clinical Trial of JX-594 in Lancet Oncology

...in the U.S. alone. These desperate patients represent a huge unmet medical need since few effective therapies are available for them. Our team here at ucsd is extremely excited to be a lead site for the current Phase II trial of JX-594 for liver cancer," said Dr. Tony Reid, M.D., Ph.D., Associate Professo...

Mayo Clinic Proceedings January Tip Sheet

...le are Karen Moeller, PharmD., Pharmacy School, University of Kansas Medical Center, Kansas City; Kelly Lee, PharmD., Department of Clinical Pharmacy, ucsd Skaggs School of Pharmacy and Pharmaceutical Sciences, La Jolla, Calif.; and Julie Kissack, PharmD., Department of Pharmacy Practice, Mercer Universit...

New Data Show Improvements in Work Performance in Patients with Chronic Insomnia Treated with AMBIEN CR(R) (zolpidem tartrate extended-release) Tablets CIV

...f chronic insomnia can improve next day functioning," said Milton Erman, MD, chief medical officer, Avastra USA, and clinical professor of psychiatry, ucsd School of Medicine. "This study demonstrates that AMBIEN CR is not only an effective treatment option to help patients with chronic insomnia fall and ...

Tezampanel, TorreyPines Therapeutics' Lead Compound, Reduced Muscle Spasticity and Rigidity in Preclinical Study Conducted at University of California, San Diego

...ata demonstrate potential utility across a range of pain conditions, as well as diseases such as epilepsy and anxiety. These exciting results from the ucsd researchers further reinforce our belief in the versatility of this first-in-class compound." Currently, patients experiencing muscle spasticity and ...

UCSD in Medical Dictionary

Radiology

...imaging ... Certifies medical specialists in radiology . Diagnostic Radiology - Musculoskeletal. Neuroradiology. Nuclear Medicine (PET) ... ucsd Radiology at La Jolla. ... Vascular Interventional Radiology ... Radiology Today newsmagazine reaches radiology professionals nationwide o...

Metabolic Diseases

...ntified and cloned, ... Metabolic Disease Center. University of California San Diego ... The Mitochondrial and Metabolic Disease Center at ucsd has the goal of raising a ... Metabolic disorders information including symptoms, diagnosis, misdiagnosis, ... Metabolic Diseases in Acidoti...

Cystinosis

...tinosis is a rare genetic disorder characterized by ... ... populations, including DR Cysteamine for potential treatment of cystinosis . ... ucsd is recruiting cystinosis patients for first clinical trial of Raptor's ... INTRODUCTION Cystinosis is a metabolic disease characterized by...

UCSD in Biological News

Caltech and UCSD researchers shed light on how proteins find their shapes

PASADENA, Calif.--Researchers from the California Institute of Technology (Caltech) and the University of California at San Diego (UCSD) have brought together UCSD theoretical modeling and Caltech experimental data to show just how amino-acid chains might fold up into unique, three-dimensional fun...

San Diego Supercomputer Center and UCSD announce 'Triton Resource'

The San Diego Supercomputer Center (SDSC) at the University of California, San Diego today announced plans for a unique facility called the Triton Resource, a high-impact, massive data analysis and storage system that will accelerate innovation, collaboration, and discovery through the use of lead...

Biodiversity maps developed by UCSD scientists will help guide conservation measures in East Africa

Conservation biologists from UC San Diego are collaborating with scientists from the African Conservation Centre and other institutions to map patterns of biodiversity and land use in East Africa in unprecedented detail. Their maps, combined with climate models, will project how climate change wil...

Moores UCSD Cancer Center study links vitamin D, type 1 diabetes

Sun exposure and vitamin D levels may play a strong role in risk of type 1 diabetes in children, according to new findings by researchers at the Moores Cancer Center at University of California, San Diego (UCSD) and the Department of Family and Preventive Medicine. This association comes on the h...

Sea cliff erosion, hemp construction materials and more at UCSD Engineering Conference

Sea cliff erosion prediction, an automatic cameraman, wall boards made from hemp and plant-based glues, computers with common sense, origami optics, privacy-preserving surveillance systems, the strength of toucan beaks, and stem cell control with nano-science are just a few of the more than 250 re...

Gene therapy protocol at UCSD activates immune system in patients with leukemia

A research team at the Moores Cancer Center at University of California, San Diego (UCSD) reports that patients with chronic lymphocytic leukemia (CLL) who were treated with a gene therapy protocol began making antibodies that reacted against their own leukemia cells. The study will be published o...

Natural tumor suppressor in body discovered by UCSD medical researchers

A natural tumor suppressor that could potentially be turned on in certain cancer cells to prevent the formation of tumors has been discovered by researchers at the University of California, San Diego (UCSD) School of Medicine. Located on chromosome 18 and called PH domain Leucine-rich repeat Pro...

Vital step in cellular migration described by UCSD medical researchers

A vital molecular step in cell migration, the movement of cells within the body during growth, tissue repair and the body's immune response to invading pathogens, has been demonstrated by researchers in the University of California, San Diego (UCSD) School of Medicine. Published in the March 27 onl...

Study may aid efforts to prevent uncontrolled cell division in cancer

...D, associate professor at the Ludwig Institute and the Department of Cellular and Molecular Medicine at UC San Diego School of Medicine and the Moores ucsd Cancer Center. "Because of this property, the time required to complete cell division remains the same during embryogenesis, even as cells get smalle...

UCSD researchers make first direct observations of biological particles in high-altitude ice clouds

...rst aircraft-based deployment of the aircraft aerosol time-of-flight mass spectrometer (A-ATOFMS) nicknamed "Shirley," which was recently developed at ucsd with funding from NSF. The ICE-L team mounted the mass spectrometer and an ice chamber run by Colorado State University researcher Paul DeMott onto a...

More>>

UCSD in Biological Technology

Poniard Pharmaceuticals to Present at the 4th Annual Moores UCSD Cancer Center Translational Oncology Symposium

SOUTH SAN FRANCISCO, Calif., July 31 /PRNewswire-FirstCall/ -- Poniard Pharmaceuticals, Inc. (Nasdaq: PARD ), a biopharmaceutical company focused on oncology, today announced that the Company will present information on platinum resistance at the Fourth Annual Moores UCSD Cancer Center Transl...

New drugs faster from natural compounds: A UC San Diego breakthrough

... author on the paper and a professor with the UC San Diego Scripps Institution of Oceanography Center for Marine Biotechnology and Biomedicine and the ucsd Skaggs School of Pharmacy and Pharmaceutical Sciences. (Read about Gerwick's work to discover drugs and protect Panama's natural and cultural resource...

Raptor Pharmaceuticals Doses First Patient in Phase 2b Clinical Trial of DR Cysteamine for Cystinosis

...open Investigational New Drug application ("IND"), ucsd is performing the Raptor-sponsored trial at its Ge..., M.D., Ph.D., Professor of Clinical Pediatrics at ucsd and principal investigator for the cystinosis clin...tential for an improved treatment invented here at ucsd and further developed by Raptor. We're pleased to ...

Life sticks: UC San Diego bioengineer's sticky insights published in journal Science

...nterdisciplinary interactions like we have here at ucsd with the Institute for Engineering in Medicine." ...nce and Biomedical Sciences. He is a member of the ucsd Stem Cell Institute and the ucsd Institute for Engineering in Medicine. Engler ...

Otonomy Introduces Scientific Advisory Board

... resident in the division of Otolaryngology at the ucsd Medical Center while earning his Ph.D. from the U...r of research in the Division of Otolaryngology at ucsd and director of otolaryngology research at the San...He also serves on the executive committees for the ucsd Neurosciences and the UCSD/SDSU audiology doctoral...

Convey Computer™ Corporation Announces First Customer: University of California, San Diego at SC08 Conference

... cost savings and reduced environmental impact with the HC-1. The HC-1 will reduce the time to completion by two orders of magnitude on a widely used ucsd bioinformatics application, InsPecT/MS-Alignment, which supports blind proteomics searches, one of the most time-consuming applications in bioinformat...

Clemson scientists put a (nano) spring in their step

... can be peeled off in one piece and placed on other surfaces to form instant cushioning coatings." In earlier studies, Rao and his team, along with ucsd collaborators, tested more conventional straight carbon nanotubes against coil-shaped nanotubes. When a stainless steel ball was dropped onto a single...

New yeast trick for eating favorite food: Details in Nature paper

...of functional proteins. This "post-transcriptional" regulation provides cells with an additional level of control over phenotypic expression. The ucsd team demonstrated that the glucose network actively shuts down the galactose network by degrading messenger RNA that would otherwise go on to form the...

Improved culture system for hepatitis C virus infection

...Buck, Ph.D., researcher at UC San Diego's Department of Medicine and Moores ucsd Cancer Center developed the novel culture system, which mimics the biology ...ined from infected patients. In contrast, the culture developed by the ucsd scientists allows direct infection with HCV genotypes 1, 2, 3 and 4 from th...

Glowing films developed by UC San Diego chemists reveal traces of explosives

... portable kit based on the technology that security officers could use with minimal training. Detection relies on fluorescent polymers developed at ucsd by chemistry and biochemistry professor William Trogler and graduate student Jason Sanchez. Its a very intuitive detection method that doesnt require ...

UCSD in Biological Definition

Glycome

... at discussing the technological aspects of the glycome challenge) which discusses Glycominds who are founding commercial co-sponsors of the CFG. ucsd article October 9 , 2001 . ...